Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019
- 17 April 2020
- journal article
- review article
- Published by Elsevier BV in Cardiovascular Pathology
- Vol. 47, 107228
- https://doi.org/10.1016/j.carpath.2020.107228
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (81670337)
- Hermann Research Foundation
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences (2019XK320061)
This publication has 74 references indexed in Scilit:
- Third Universal Definition of Myocardial InfarctionCVD Prevention and Control, 2012
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune ResponseJournal of Virology, 2011
- Upregulation of the Chemokine (C-C Motif) Ligand 2 via a Severe Acute Respiratory Syndrome Coronavirus Spike-ACE2 Signaling PathwayJournal of Virology, 2010
- SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARSEuropean Journal of Clinical Investigation, 2009
- Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entryProceedings of the National Academy of Sciences of the United States of America, 2008
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Cardiovascular complications of severe acute respiratory syndromePublished by Oxford University Press (OUP) ,2006
- Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial CellsCirculation Research, 2004
- A Human Homolog of Angiotensin-converting EnzymeOnline Journal of Public Health Informatics, 2000
- Myocardial oxygen consumption: The quest for its determinants and some clinical falloutJournal of Invasive Cardiology, 2000